Patents by Inventor Juliana J. Oh

Juliana J. Oh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnostic and therapeutic methods using the H37 tumor suppressor gene
    Patent number: 6929910
    Abstract: The present invention relates to the identification of the H37 tumor suppressor gene and methods of diagnosing and treating a disease or disorder characterized by abnormal cellular proliferation, such as a tumor or cancer. Diagnosis is accomplished examining or monitoring cells for perturbations in H37 expression or function. Treatment is accomplished by inserting a host cell compatible H37 expression vector or an effective amount of H37 protein into a cell or cells in need of treatment.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: August 16, 2005
    Assignee: The Regents of the University of California
    Inventors: Dennis J. Slamon, Juliana J. Oh
  • Differentially expressed genes associated with HER-2/neu overexpression
    Patent number: 6770477
    Abstract: The present invention provides human Her-2/neu overexpression modulated proteins (HOMPS) and polynucleotides encoding HOMPS polypeptides. The invention also provides HOMPS containing expression vectors and host cells, HOMPS antibodies and methods of producing HOMPS. In addition, the invention provides methods for generating, identifying and manipulating HOMPS.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: August 3, 2004
    Assignee: The Regents of the University of California
    Inventors: Dennis J. Slamon, Juliana J. Oh
  • Diagnostic and therapeutic methods using the H37 tumor suppressor gene
    Publication number: 20030225008
    Abstract: The present invention relates to the identification of the H37 tumor suppressor gene and methods of diagnosing and treating a disease or disorder characterized by abnormal cellular proliferation, such as a tumor or cancer. Diagnosis is accomplished examining or monitoring cells for perturbations in H37 expression or function. Treatment is accomplished by inserting a host cell compatible H37 expression vector or an effective amount of H37 protein into a cell or cells in need of treatment.
    Type: Application
    Filed: September 21, 2001
    Publication date: December 4, 2003
    Applicant: The Regents of the University of California
    Inventors: Dennis J. Slamon, Juliana J. Oh